(Total Views: 275)
Posted On: 01/02/2024 9:03:24 AM
Post# of 36541
Hey everyone,
first of all happy new New year to everyone reading this.
now to your post (and thanks to everyone for posting the little bits of information that came out in the meantime (while I have not even bothered to check into this forum, sorry about this ))
.... It still remains a mystery to me how this all is/was possible. Olaregen, Oral-Lyn, the II-key technology (just to name a prominent few) all separately are supposed to have double digit million dollar values that belongs to GNBT (and thus to US, the GNBT shareholders) and it should be unlawful that all this be sold to a Chinese company for $ 10k.
What friggin happened to the planned role out of Excellagen to US market by Olaregen based on a line of credit ready to be signed in the days after the last investor conference call in May 2021? This was supposed to be as good as a license to print money, as we've been told by the management team back then. Quickly this was supposed to reach double digit and another year later triple digit million dollars in sales!?
Oral-Lyn is a phase III clinical trial drug... and this Barnat guy is not able to find a buyer, who is willing to pay more than 10k USD? Even when he tosses the proprietary drug delivery system RapidMist into the hat as well?
Come on, no one can tell me that he even really tried to get a little bit of recovery for us, or would anyone disagree?
The way all this unfolded still totally blows my mind! Is there really nothing (more) that we or anyone could do about all this?
first of all happy new New year to everyone reading this.
now to your post (and thanks to everyone for posting the little bits of information that came out in the meantime (while I have not even bothered to check into this forum, sorry about this ))
.... It still remains a mystery to me how this all is/was possible. Olaregen, Oral-Lyn, the II-key technology (just to name a prominent few) all separately are supposed to have double digit million dollar values that belongs to GNBT (and thus to US, the GNBT shareholders) and it should be unlawful that all this be sold to a Chinese company for $ 10k.
What friggin happened to the planned role out of Excellagen to US market by Olaregen based on a line of credit ready to be signed in the days after the last investor conference call in May 2021? This was supposed to be as good as a license to print money, as we've been told by the management team back then. Quickly this was supposed to reach double digit and another year later triple digit million dollars in sales!?
Oral-Lyn is a phase III clinical trial drug... and this Barnat guy is not able to find a buyer, who is willing to pay more than 10k USD? Even when he tosses the proprietary drug delivery system RapidMist into the hat as well?
Come on, no one can tell me that he even really tried to get a little bit of recovery for us, or would anyone disagree?
The way all this unfolded still totally blows my mind! Is there really nothing (more) that we or anyone could do about all this?
(2)
(0)Scroll down for more posts ▼
